C12N 15/63
Introduction of foreign genetic material using vectors
Official title: Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
C12N15/63 (Introduction of foreign genetic material using vectors) appears on 39,044 US grants and 58,143 published applications in this corpus.
Search patents in C12N- Granted patents
- 39,044
- Published applications
- 58,143
- Assignees
- 11,784
- Inventors
- 82,393
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 2 | 0 |
| 1982 | 10 | 0 |
| 1983 | 16 | 0 |
| 1984 | 27 | 0 |
| 1985 | 29 | 0 |
| 1986 | 41 | 0 |
| 1987 | 71 | 0 |
| 1988 | 97 | 0 |
| 1989 | 132 | 0 |
| 1990 | 152 | 0 |
| 1991 | 166 | 0 |
| 1992 | 235 | 0 |
| 1993 | 268 | 0 |
| 1994 | 252 | 0 |
| 1995 | 270 | 0 |
| 1996 | 474 | 0 |
| 1997 | 747 | 0 |
| 1998 | 1020 | 0 |
| 1999 | 1045 | 0 |
| 2000 | 922 | 0 |
| 2001 | 1023 | 198 |
| 2002 | 881 | 1346 |
| 2003 | 886 | 2264 |
| 2004 | 733 | 1721 |
| 2005 | 604 | 1641 |
| 2006 | 879 | 1659 |
| 2007 | 905 | 1310 |
| 2008 | 726 | 1487 |
| 2009 | 808 | 1777 |
| 2010 | 1012 | 1745 |
| 2011 | 969 | 1887 |
| 2012 | 1023 | 1632 |
| 2013 | 1009 | 1929 |
| 2014 | 1242 | 2165 |
| 2015 | 1532 | 2143 |
| 2016 | 1584 | 2146 |
| 2017 | 1652 | 2123 |
| 2018 | 1620 | 2302 |
| 2019 | 1712 | 2903 |
| 2020 | 1790 | 3061 |
| 2021 | 1812 | 3112 |
| 2022 | 1819 | 3499 |
| 2023 | 1663 | 3802 |
| 2024 | 1700 | 3892 |
| 2025 | 1984 | 3653 |
| 2026 | 1499 | 2746 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 15/79Vectors or expression systems specially adapted for eukaryotic hosts31,494
- C12N 15/70Vectors or expression systems specially adapted for e. coli3,043
- C12N 15/74Vectors or expression systems specially adapted for prokaryotic hosts other than e.2,993
- C12N 15/67General methods for enhancing the expression1,624
- C12N 15/66General methods for inserting a gene into a vector to form a695
- C12N 15/64General methods for preparing the vector, for introducing it into the cell593
- C12N 15/635Externally inducible repressor mediated regulation of gene expression390
- C12N 15/65Using markers288
Recent patents
- Preventing and treating amyloid-beta deposition by stimulation of innate immunity6 Oct 2026US 12,751,964 B2New York University
- Tumor-targeting Salmonella gallinarum strain and use thereof6 Oct 2026US 12,751,978 B2Industry Foundation of Chonnam National University
- Methods and materials for ameliorating creatine deficiency disorders6 Oct 2026US 12,751,995 B2The Regents of the University of California
- BCMA chimeric antigen receptors6 Oct 2026US 12,752,006 B2Regeneron Pharmaceuticals, Inc.
- Engineered meganucleases having specificity for a recognition sequence in the hydroxyacid oxidase 1 gene6 Oct 2026US 12,752,019 B2Precision BioSciences, Inc.
- Transgenic model of human cardiomyopathy8 Oct 2026US 2026/0305586 A1Stichting Genetische Hartspierziekte PLN
- Methods and compositions for microbial delivery of double stranded rna8 Oct 2026US 2026/0305618 A1Rnaissance AG LLC
- Hydrogel ink, hydrogel and uses thereof8 Oct 2026US 2026/0306528 A1
- Targeted Immune Cell Therapy Utilizing TRAIL and TNF Mediated Apoptosis8 Oct 2026US 2026/0306542 A1Northeastern University
- Recombinant expression vector for interferon-beta secretion and attenuated salmonella strain transformed by means of same8 Oct 2026US 2026/0306554 A1The Industry & Academic Cooperation in Chungnam National University (IAC)
Most cited
By later US patents
- Mutant dwarfism gene of petunia5,133US 5,523,520 AGoldsmith Seeds, Inc. · 1996
- Recombinant immunoglobin preparations4,785US 4,816,567 AGenentech, Inc. · 1989
- Soybean transformation and regeneration methods2,169US 5,968,830 AMississippi State University · 1999
- Soybean event MON89788 and methods for detection thereof2,074US 7,632,985 B2Monsanto Technology LLC · 2009
- Ransgenic non-human animals for producing heterologous antibodies1,941US 5,545,806 AGenPharm International, Inc. · 1996